Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for Neovascular Membranes in Intraocular Inflammation
NCT00407121Phase 3Withdrawn
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Dec 2006
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in Vogt-Koyanagi-Harada disease (VKH), serpiginous choroiditis (SC), multifocal choroiditis (MFC), sponsored by Asociación para Evitar la Ceguera en México. Planned start Dec 2006; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
Vogt-Koyanagi-Harada disease (VKH)serpiginous choroiditis (SC)multifocal choroiditis (MFC)
Beyond the preview
Go deeper on NCT00407121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407121.